rs139287714
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The NM_022124.6(CDH23):āc.1301A>Gā(p.Asn434Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000129 in 1,613,652 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_022124.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH23 | NM_022124.6 | c.1301A>G | p.Asn434Ser | missense_variant | Exon 14 of 70 | ENST00000224721.12 | NP_071407.4 | |
CDH23 | NM_001171930.2 | c.1301A>G | p.Asn434Ser | missense_variant | Exon 14 of 32 | NP_001165401.1 | ||
CDH23 | NM_001171931.2 | c.1301A>G | p.Asn434Ser | missense_variant | Exon 14 of 26 | NP_001165402.1 | ||
CDH23 | NM_052836.4 | c.1301A>G | p.Asn434Ser | missense_variant | Exon 14 of 14 | NP_443068.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000717 AC: 109AN: 152068Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000141 AC: 35AN: 249008Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135064
GnomAD4 exome AF: 0.0000677 AC: 99AN: 1461466Hom.: 0 Cov.: 31 AF XY: 0.0000605 AC XY: 44AN XY: 726990
GnomAD4 genome AF: 0.000716 AC: 109AN: 152186Hom.: 1 Cov.: 33 AF XY: 0.000632 AC XY: 47AN XY: 74414
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
- -
- -
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Asn434Ser var iant in CDH23 has been previously identified by our laboratory in 1 individual w ith hearing loss who did not carry a second CDH23 variant. This variant has also been identified in 0.2% (24/9802) of African chromosomes by the Exome Aggregati on Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs139287714). Althoug h this variant has been seen in the general population, its frequency is not hig h enough to rule out a pathogenic role. Computational prediction tools and conse rvation analyses suggest that this variant may impact the protein, though this i nformation is not predictive enough to determine pathogenicity. In summary, the clinical significance of this variant cannot be determined with certainty; howev er, the frequency data suggest that it is more likely to be benign. -
Usher syndrome type 1 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at